Franco Poletti - 30 Mar 2025 Form 4 Insider Report for LivaNova PLC (LIVN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Apr 2025, 21:00:26 UTC
Prior SEC filing
17 Dec 2024
Next SEC filing
17 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sarah K. Mohr, Attorney-in-Fact

Key filing fact

Franco Poletti filed Form 4 for LivaNova PLC (LIVN) on 01 Apr 2025.

Key facts

  • This page summarizes Franco Poletti's Form 4 filing for LivaNova PLC (LIVN).
  • 11 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 01 Apr 2025, 21:00.

Change

  • Previous filing in this sequence was filed on 17 Dec 2024.
  • Current net transaction value: -$21,208.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIVN transaction

Ordinary Shares

Options Exercise

Transaction value
$0
Shares
+1,257
Change %
+17%
Price
$0.000000
Shares after
8,475
Date
30 Mar 2025
Ownership
Direct
Footnotes
F1
LIVN transaction

Ordinary Shares

Tax liability

Transaction value
$21,208
Shares
-542
Change %
-6.4%
Price
$39.13
Shares after
7,933
Date
30 Mar 2025
Ownership
Direct
LIVN holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
219
Date
30 Mar 2025
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LIVN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-201
Change %
-100%
Price
$0.000000
Shares after
0
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
201
Exercise price
Footnotes
F2, F3
LIVN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-172
Change %
-50%
Price
$0.000000
Shares after
171
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
172
Exercise price
Footnotes
F2, F4
LIVN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-325
Change %
-33%
Price
$0.000000
Shares after
650
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
325
Exercise price
Footnotes
F5, F6
LIVN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-559
Change %
-25%
Price
$0.000000
Shares after
1,675
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
559
Exercise price
Footnotes
F5, F7
LIVN transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+6,388
Change %
Price
$0.000000
Shares after
6,388
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,388
Exercise price
Footnotes
F5, F8
LIVN transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+3,194
Change %
Price
$0.000000
Shares after
3,194
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
3,194
Exercise price
Footnotes
F9, F10
LIVN transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+3,194
Change %
Price
$0.000000
Shares after
3,194
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
3,194
Exercise price
Footnotes
F9, F11
LIVN transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+6,388
Change %
Price
$0.000000
Shares after
6,388
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,388
Exercise price
Footnotes
F9, F12
LIVN transaction Derivative

Stock Appreciation Rights

Award

Transaction value
$0
Shares
+13,986
Change %
Price
$0.000000
Shares after
13,986
Date
30 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
13,986
Exercise price
$39.13
Footnotes
F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Footnote F2

Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

Footnote F3

On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

Footnote F4

On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.

Footnote F5

Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

Footnote F6

On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Footnote F7

On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Footnote F8

On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Footnote F9

Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

Footnote F10

On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Footnote F11

On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Footnote F12

On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

Footnote F13

On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .